Source Citation
Abraham NS, Singh S, Alexander GC, et al. Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study. BMJ. 2015;350:h1857. https://pubmed.ncbi.nlm.nih.gov/25910928
Clinical Impact Ratings
GIM/FP/GP: 
Gastroenterology: 
Hematology:
References
- 1. Holster IL, Valkhoff VE, Kuipers EJ, Tjwa ET. New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology. 2013;145:105-112.e15. [PMID:
23470618 ] Google Scholar - 2. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955-62. [PMID:
24315724 ] Google Scholar
Author, Article and Disclosure Information
Affiliations:
Olive View–UCLA Medical Center, Sylmar, California, USA (R.L.K.)
This article was published at Annals.org on 1 September 2015.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.